EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dynamic Organelle Remodeling in HIV-Associated Myocardial Disease: Mechanisms, Fibrotic Pathways, and Therapeutic Opportunities

Katongo Hope Mutengo, Sepiso Kenias Masenga iD, Annet Kirabo iD

Current Issues in Molecular Biology · 02.04.2026 · 48 (4) · 371

DOI: 10.3390/cimb48040371 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 02.04.2026. Verfasst von Katongo Hope Mutengo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Ministry of Health, Monze Mission Hospital, Monze 10101, Zambia. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with HIV experience a disproportionate burden of myocardial fibrosis and diastolic dysfunction that is not fully explained by traditional cardiovascular risk factors or systemic inflammation. Emerging evidence suggests that HIV-associated cardiomyopathy originates from persistent disturbances in cardiomyocyte homeostasis driven by chronic immune-metabolic stress. Metabolic dysregulation, antiretroviral-related toxicity, and residual inflammatory signaling converge at the cardiomyocyte organelle level, leading to mitochondrial dysfunction, endoplasmic reticulum stress, and impaired autophagy. These interrelated processes precede overt structural heart disease and promote progressive myocardial stiffening, despite effective viral suppression. Framing myocardial remodeling as a consequence of unresolved organelle stress highlights opportunities for earlier intervention, including aggressive management of metabolic risk factors, the use of established cardioprotective therapies with antifibrotic effects, and emerging strategies targeting mitochondrial and proteostatic pathways. This organelle-centered perspective supports prevention-focused approaches that combine accessible imaging modalities and circulating biomarkers to mitigate the long-term cardiovascular risk in people with HIV, particularly in resource-limited settings.

Schlagwörter

Stichwörter der Autor:innen

HIVfibrosismitochondrialmyocardialorganelleremodeling

Autor:innen und Institutionen

  • Department of Internal Medicine, Ministry of Health, Monze Mission Hospital, Monze 10101, Zambia.
  • Department of Internal Medicine, School of Medicine, University of Zambia, Lusaka 10101, Zambia.
  • Department of Medicine, Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37235, USA.
  • Department of Pathology, Mulungushi University, Livingstone 10101, Zambia.
  • Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN 37235, USA.

ORCID-Profile: Sepiso Kenias Masenga, Annet Kirabo

Zitieren

APA

Mutengo, K. H., Masenga, S. K., & Kirabo, A. (2026). Dynamic Organelle Remodeling in HIV-Associated Myocardial Disease: Mechanisms, Fibrotic Pathways, and Therapeutic Opportunities. Current Issues in Molecular Biology, 48(4), 371. https://doi.org/10.3390/cimb48040371

Vancouver

Mutengo KH, Masenga SK, Kirabo A. Dynamic Organelle Remodeling in HIV-Associated Myocardial Disease: Mechanisms, Fibrotic Pathways, and Therapeutic Opportunities. Current Issues in Molecular Biology. 2026;48(4):371. doi:10.3390/cimb48040371

BibTeX
@article{Mutengo2026,
  author = {Mutengo, Katongo Hope and Masenga, Sepiso Kenias and Kirabo, Annet},
  title = {Dynamic Organelle Remodeling in HIV-Associated Myocardial Disease: Mechanisms, Fibrotic Pathways, and Therapeutic Opportunities},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {4},
  pages = {371},
  doi = {10.3390/cimb48040371}
}
Kostenlos starten →